companydata.dkcompanydata.dk

EUROLYSE IVS: Financial statements 2024

CVR: 36462191

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

EUROLYSE IVS (CVR 36462191) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 100. The solvency ratio was 100%.

Revenue
DKK 0
Equity
DKK 100

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024000100-
2023000100-
2022000100-
2021000100-
2020000100-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

EUROLYSE IVS: The 2023 annual report is outJun 28, 2024

EUROLYSE IVS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 0.

About EUROLYSE IVS

EUROLYSE IVS was a Danish company of the type Iværksætterselskab based in Frederikssund, founded in 2014. The company has been dissolved on 22 January 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CRETECSYS IVS. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 100.

Source: annual report 2024, Danish Business Authority